Also Cyp has treated 165 patients in Osteoarthritis without generating an adverse event worthy of reporting. And these 165 patients received multiple injections. So we’re looking at close to 400 doses of Cymerus cells without triggering an event that would halt recruitment.
- Forums
- ASX - By Stock
- CYP
- Ann: Encouraging Initial Data from CYP-006TK DFU Trial
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-41
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 25.0¢ | $3.097K | 12.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29341 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 11015 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29341 | 0.250 |
1 | 2500 | 0.245 |
4 | 107225 | 0.240 |
1 | 100000 | 0.235 |
3 | 36912 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.270 | 30000 | 1 |
0.280 | 3000 | 1 |
0.290 | 4125 | 2 |
0.295 | 183892 | 1 |
0.300 | 85000 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
CYP (ASX) Chart |